ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,214,000 | -30.4% | 54,785 | -0.8% | 0.01% | -14.3% |
| Q2 2015 | $3,180,000 | -88.2% | 55,244 | -86.9% | 0.01% | -88.3% |
| Q1 2015 | $26,936,000 | -25.2% | 423,053 | -27.5% | 0.06% | -25.0% |
| Q4 2014 | $36,011,000 | +60.9% | 583,258 | +1.2% | 0.08% | +56.9% |
| Q3 2014 | $22,375,000 | +117.4% | 576,237 | +92.8% | 0.05% | +112.5% |
| Q2 2014 | $10,294,000 | +258.7% | 298,812 | +349.9% | 0.02% | +242.9% |
| Q1 2014 | $2,870,000 | +8.5% | 66,412 | 0.0% | 0.01% | +16.7% |
| Q4 2013 | $2,646,000 | +9.0% | 66,412 | +2.7% | 0.01% | 0.0% |
| Q3 2013 | $2,427,000 | +39.7% | 64,658 | 0.0% | 0.01% | +20.0% |
| Q2 2013 | $1,737,000 | – | 64,658 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |